Bone-building bonus

Women who take alendronate and other bisphosphonate drugs used to treat bone-thinning osteoporosis may have a lower risk of cardiovascular ‘events’. chinese researchers who followed up 18,000 patients after hip fractures between 2005 and 2016, report that those taking bisphosphonates were less likely to have a heart attack/stroke (or die) in the first few years after starting treatment.